Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Connect Biopharma Holdings Inc | CNTB | NASDAQ | Certificat de dépôt |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
1,34 | 1,31 | 1,40 | 1,37 |
Actualités Recentes
Date | Heure | Source | Titre |
---|---|---|---|
28/2/2024 | 03:00 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
13/2/2024 | 22:30 | EDGAR2 | Form SC 13D - General statement of acquisition of beneficial.. |
13/2/2024 | 22:27 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
13/2/2024 | 22:18 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
12/2/2024 | 22:50 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
12/12/2023 | 12:10 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
21/11/2023 | 12:13 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
01/11/2023 | 20:57 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
20/10/2023 | 22:44 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
12/9/2023 | 22:47 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
12/9/2023 | 12:13 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
14/7/2023 | 23:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |